Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHC.L Regulatory News (PHC)

  • There is currently no data for PHC

Trading Statement

27 Jan 2010 07:00

RNS Number : 1723G
Plant Health Care PLC
27 January 2010
 



For release: 7am, 27 January 2010 

 

PLANT HEALTH CARE PLC

("Plant Health Care" or "the Company")

Trading Update

Plant Health Care (AIM: PHC.L), a leading provider of naturally derived products to the agriculture and landscape industries, provides the following post year end update for 2009, ahead of the announcement of its full year results, which is expected on 15 February 2010.

The Company is pleased to announce that it has continued to make excellent progress with its strategic priorities, particularly in its relationships with Monsanto and Scotts. Furthermore, despite difficult trading conditions in the United States as a result of the recessionary economic climate and following the pre-tax loss of $3.9 million incurred in the first half of the year, the Company has traded profitably in the last six months. In consequence, the Company expects to report a significantly reduced full year loss, in line with market expectations.

The Company has continued to make excellent progress in its partnership with Monsanto with significantly larger orders placed for Harpin (for use on Soybean), during 2009, than had originally been expected. Moreover, it continues to be in discussions regarding the use of Harpin on other crops than soybean and remains confident of reaching a conclusion to those discussions before the end of the Summer, with a consequent positive impact on the company's earnings in 2010.

As relationships with the Company's major customers have developed it has become clear that in the future, they will wish to align the timing of their purchasing of Harpin and other products more closely with their use. The Board is therefore adjusting its market guidance for 2010, and beyond, to recognise that at least one third of sales previously expected to fall in 2010 are now likely to fall in to the following year.

The cash position as at 31 December 2009 was $15.9 million (2008: $7.3 million), benefitting from tight cash management and the £10.5 million of new funds raised from the placing in May 2009.

The Company continues to be in advanced discussions with a wide variety of potential partners for both Harpin, as a foliar spray in combination with herbicides and fungicides, and for Myconate and remains confident that it will be in a position to conclude partnership deals on both these products before the end of 2010. 

John Brady, Chief Executive of Plant Health Care said: "2009 was an excellent year for Plant Health Care. For the first time one of our natural technologies will be on millions of acres and interest in our sustainable, naturally derived technologies is high. I look forward to providing more detail to our shareholders in February.

-Ends-

For further information please contact:

Plant Health Care plc

John Brady, Chief Executive Officer

Tel: +1-603-525-3702

jabrady@planthealthcare.com

Evolution Securities

Tavistock Communications 

Tim Worlledge / Tim Redfern

Jeremy Carey/Matt Ridsdale

Tel: +44-20-7071-4300 

Tel: +44-20-7920-3150

tim.worlledge@evosecuties.com/

tim.redfern@evosecuties.com

jcarey@tavistock.co.uk

mridsdale@tavistock.co.uk


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTLLFVALFIRFII
Date   Source Headline
20th Apr 20227:00 amRNSHolding(s) in Company
19th Apr 20221:46 pmRNSNotice of results and investor presentation
11th Apr 202212:52 pmRNSHolding(s) in Company
1st Apr 20227:00 amRNSNew Distribution agreement with Ager Agro
14th Mar 202212:49 pmRNSHolding(s) in Company
11th Mar 202212:19 pmRNSHolding(s) in Company
3rd Feb 202212:56 pmRNSHolding(s) in Company
1st Feb 20221:16 pmEQSPlant Health Care, plc
1st Feb 20227:00 amRNS2021 Trading Statement
31st Jan 20227:00 amRNSPHC949 product registration submitted to the EPA
17th Jan 20227:00 amRNSInvestor Presentation
15th Dec 20217:00 amRNSWilbur Ellis and Plant Health Care discussion
13th Dec 20217:00 amRNSCommercial scale manufacturer for Saori
30th Nov 20214:36 pmRNSPrice Monitoring Extension
20th Oct 20216:03 pmRNSExercise of Options
22nd Sep 20217:00 amRNSNew agreement with Nutrien for Saori launch
22nd Sep 20217:00 amRNSInterim Report 30 June 2021
21st Sep 20214:41 pmRNSSecond Price Monitoring Extn
21st Sep 20214:35 pmRNSPrice Monitoring Extension
1st Sep 20217:00 amRNSArgentina approves Harpin as a seed treatment
24th Aug 20217:00 amRNSInvestor Presentation
18th Aug 20214:41 pmRNSSecond Price Monitoring Extn
18th Aug 20214:36 pmRNSPrice Monitoring Extension
9th Aug 20211:27 pmRNSHolding(s) in Company
3rd Aug 20217:00 amRNSAdmission to the U.S. OTCQB Venture Market
27th Jul 20217:00 amRNSNew Distribution Agreement with Agrii UK
26th Jul 20217:00 amRNS2021 Half-Year Trading Statement
23rd Jul 20217:00 amRNSGrant of Options
22nd Jul 20217:00 amRNSInvestor Presentation
12th Jul 20214:40 pmRNSSecond Price Monitoring Extn
12th Jul 20214:35 pmRNSPrice Monitoring Extension
29th Jun 20214:41 pmRNSSecond Price Monitoring Extn
29th Jun 20214:35 pmRNSPrice Monitoring Extension
14th Jun 20212:33 pmRNSResult of AGM
14th Jun 20217:00 amRNSGreen Economy Mark awarded
9th Jun 20214:41 pmRNSSecond Price Monitoring Extn
9th Jun 20214:35 pmRNSPrice Monitoring Extension
20th May 20217:00 amRNSInvestor Presentation
7th May 20213:50 pmRNSAnnual Report & Accounts and AGM Notice Published
30th Apr 20215:40 pmRNSHolding(s) in Company
23rd Apr 20217:00 amRNSResults for the year ended 31 December 2020
21st Apr 202111:58 amRNSHolding(s) in Company
8th Apr 20213:30 pmRNSHolding(s) in Company
1st Apr 20217:00 amRNSTotal Voting Rights
22nd Mar 20217:00 amRNSInvestor Presentation
18th Mar 20211:57 pmRNSResults of Placing and Subscription
18th Mar 20217:00 amRNSProposed Placing and Subscription
1st Mar 20217:00 amRNSSaori Trial Update
3rd Feb 20214:41 pmRNSSecond Price Monitoring Extn
3rd Feb 20214:36 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.